Translational and Clinical Research in Cancer Program
This Research Program is composed of groups interested in the direct translation of results from the lab to the bench side. To this end, they work on the validation of drug targets, the design of new therapeutic avenues based on single and combinatorial therapies, the understanding of therapeutic resistance and posttreatment recurrence, and the genomic characterization of tumors during both pre- and post-treatment windows. They are also engaged in an extensive number of clinical trials. This Program also has support groups that enable robust Bioinformatics and System Biology analyses. In addition, they benefit from other health-related initiatives coordinated by our Center such as the Castilla-León Regional Tumor BioBank, the Familiar Cancer Detection Unit, and the Molecular Diagnostic Unit.